Handbook of Psychopharmacology Volume 13 Biology of Mood and Antianxiety Drugs

Handbook of Psychopharmacology Volume 13 Biology of Mood and Antianxiety Drugs / edited by Leslie Iversen.

Underlying the design of the Handbook of Psychopharmacology is a prejudice that the study of drug influences on the mind has advanced to a stage where basic research and clinical application truly mesh. These later volumes of the Handbook are structured according to this conception. In certain volum...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Iversen, Leslie (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 1978.
Edition:1st ed. 1978.
Series:Springer eBook Collection.
Subjects:
Pharmacology.
Psychopharmacology.
Psychology.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • 1 Peptides and the Central Nervous System
  • 1. Introduction
  • 2. Hypothalamic Releasing Hormones: Animal Studies
  • 3. Pituitary Peptide Hormones: Animal Studies
  • 4. Other Brain Peptides: Animal Studies
  • 5. Hypothalamic Releasing Hormones: Human Studies
  • 6. Pituitary Peptide Hormones: Human Studies
  • 7. Discussion
  • 8. References
  • 2 The Limbic-Hypothalamic-Pituitary-Adrenal System and Human Behavior
  • 1. Introduction
  • 2. Description of the Limbic-Hypothalamic-Pituitary-Adrenal System
  • 3. Procedures for Evaluating LHPA Function in Humans
  • 4. Relationship between Mental Phenomena and the LHPA System
  • 5. Summary
  • 6. References
  • 3 Approaches to Brain Amines in Psychiatric Patients: A Reevaluation of Cerebrospinal Fluid Studies
  • 1. Introduction
  • 2. Methodological Considerations for Spinal Fluid Studies
  • 3. CSF Amine Metabolites in Affective Illness
  • 4. Amine Metabolism in Schizophrenic Patients
  • 5. Pharmacological Approaches: Integration with Amine Metabolite Data
  • 6. Theoretical Overview: The Question of Specificity
  • 7. A Model for Defects in Compensatory and Regulatory Mechanisms
  • 8. References
  • 4 Amine Hypotheses of Affective Disorders
  • 1. Introduction
  • 2. Classification of Depressions
  • 3. Serotonin Metabolism in Affective Disorders: Study of Peripheral Indicators
  • 4. Metabolism of Catecholamines in Affective Disorders: Study of Peripheral Indicators
  • 5. Postmortem Study of Central Monoamine Metabolism in Depressions
  • 6. Central Monoamine Metabolism in Affective Disorders: CSF Studies Without Probenecid
  • 7. Central Monoamine Metabolism in Affective Disorders: CSF Studies After Probenecid Loading
  • 8. Verification of the Monoamine Hypothesis with the Aid of Drugs: I. Monoamine Precursors and Synthesis Inhibitors
  • 9. Verification of the Monoamine Hypothesis with the Aid of Drugs and Other Methods of Antidepressant Therapy: II. Direct Influencing of the Transmission Process
  • 10. Theories to Explain the Monoamine Deficiency in Depressions
  • 11. Preliminaries to Expansion of the Monoamine Hypothesis 270 11.1 Acetylcholine
  • 12. General Conclusions
  • 13. References
  • 5 Clinical Pharmacokinetics of Selected Psychotropic Drugs
  • 1. Introduction
  • 2. Tricyclic Antidepressants
  • 3. Lithium
  • 4. Benzodiazepines
  • 5. CNS Stimulants (Amphetamine)
  • 6. Chlorpromazine
  • 7. Conclusion
  • 8. References
  • 6 Behavioral Pharmacology of Antianxiety Drugs
  • 1. Introduction
  • 2. Anticonflict Properties of Antianxiety Agents
  • 3. Properties of Antianxiety Agents in Miscellaneous Operant Conditioning Situations
  • 4. Properties of Antianxiety Agents in Additional Behavioral Procedures
  • 5. Concluding Remarks
  • 6. References
  • 7 Antianxiety Drugs: Clinical Use in Psychiatry
  • 1. Introduction
  • 2. Using Drugs to Treat Anxiety
  • 3. Improving Specific Symptom Profiles of Anxious Patients
  • 4. Predicting Improvement in Anxious Patients
  • 5. Conclusion
  • 6. References.

Similar Items